These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 704768)

  • 21. Striatal histone modifications in models of levodopa-induced dyskinesia.
    Nicholas AP; Lubin FD; Hallett PJ; Vattem P; Ravenscroft P; Bezard E; Zhou S; Fox SH; Brotchie JM; Sweatt JD; Standaert DG
    J Neurochem; 2008 Jul; 106(1):486-94. PubMed ID: 18410512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of baclofen and haloperidol on gamma-aminobutyric acid and dopamine systems in an animal model of tardive dyskinesia.
    Rastogi SK; Rastogi RB; Lapierre YD; Singhal RL
    Gen Pharmacol; 1982; 13(6):499-504. PubMed ID: 7152230
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of striatal dopaminergic supersensitivity for the evaluation of drugs with possible antidyskinetic properties.
    Valchár M; Krejcí I; Kasafírek E; Schuh J; Dlabac A
    Pol J Pharmacol Pharm; 1985; 37(3):311-5. PubMed ID: 2866500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA; Lee CS; Björklund A
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
    Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
    Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2009 Jan; 91(3):423-9. PubMed ID: 18789960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexisting tardive dyskinesia and parkinsonism: a case report.
    De Fraites EG; Davis KL; Berger PA
    Biol Psychiatry; 1977 Apr; 12(2):267-72. PubMed ID: 857938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms underlying tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():433-46. PubMed ID: 826999
    [No Abstract]   [Full Text] [Related]  

  • 30. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.
    Lundblad M; Picconi B; Lindgren H; Cenci MA
    Neurobiol Dis; 2004 Jun; 16(1):110-23. PubMed ID: 15207268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements.
    Bester AM; Harvey BH
    Metab Brain Dis; 2000 Dec; 15(4):275-85. PubMed ID: 11383552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of aging and striatal nitric oxide synthase activity in an animal model of tardive dyskinesia.
    Harvey BH; Nel A
    Brain Res Bull; 2003 Aug; 61(4):407-16. PubMed ID: 12909284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
    Guigoni C; Dovero S; Aubert I; Li Q; Bioulac BH; Bloch B; Gurevich EV; Gross CE; Bezard E
    Eur J Neurosci; 2005 Jul; 22(1):283-7. PubMed ID: 16029219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)].
    Sayers AC; Bürki HR
    Arzneimittelforschung; 1976; 26(6):1092-3. PubMed ID: 989384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 40. Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study.
    Reynolds GP; Brown JE; McCall JC; Mackay AV
    J Neural Transm Gen Sect; 1992; 87(3):225-30. PubMed ID: 1533773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.